Adding Metastasis-Directed Radiation Therapy Boosts Progression-Free Survival in Metastatic Pancreatic Cancer
Imaging Technology
AUGUST 8, 2024
assistant professor of Gastrointestinal Radiation Oncology. “We We are excited to see that the addition of targeted radiation therapy quadrupled the average progression-free survival time, suggesting this approach potentially represents a paradigm shift in treating metastatic pancreatic cancer.”
Let's personalize your content